This coming Wednesday is 'liberation day' - at least, that's what Donald Trump is calling it.
It marks the day when his administration will roll out a whole new wave of tariffs targetting things like the auto industry in Canada and potentially also the pharmaceutical and med-tech industry in Ireland.
Trump's administration feels that more of of the industry's revenue and jobs should be located in America rather than in Ireland.

Adjunct Professor in Economics at Trinity College Dublin John Fitzgerald told The Anton Savage Show that we have no idea about the potential impact of this announcement.
"He talked about Ireland and pharmaceuticals, he's talked about a whole load of things - until we see what he announces next week, we don't know," he said.
"It's likely to be pan-European and I think that is Ireland's strength is we're part of the EU.
"Also in terms of pharmaceutical imports into the United States, Switzerland actually sells more into the US than Ireland, Germany would be close enough as is Belgium, so it's not just Ireland.
"It is for us a very really important part of our relationship with the US, but the US imports about $150 billion worth of pharmaceuticals, we contribute about $25 billion of that."
Prof Fitzgerald said the US also exports around $40 billion of pharmaceuticals into Europe, so this is a "complicated business".
You can listen back to the full interview here:
Main image: U.S President Donald Trump. Credit: Daniel Torok/White House Photo/Alamy Live News. 13th Mar, 2025.